.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Capsules held 67.01% share with year-over-year growth of 93.79% and month-over-month decline of 3.96%, while Concentrates accounted for 24.00% share with 113.57% YoY growth but a 38.02% MoM drop; Vapor Pens rose to 6.01% share on a 316.54% MoM surge, and Pre-Roll captured 2.98% share with 16.24% YoY growth. Despite overall brand sales up 106.70% YoY and average price up 1.96%, mix volatility is evident as growth concentrates in Capsules and Vapor Pens, implying Persy is leaning into lower-ticket Capsules for scale while testing higher-price Concentrates and Vapor Pens for incremental reach.
Capsules anchoring two-thirds of sales alongside a rank of 16 in Capsules in Ontario signals defensible placement, yet the 38.02% MoM contraction in Concentrates and a simultaneous 316.54% MoM jump in Vapor Pens indicate substitution toward inhalable formats at very different price points. With Capsules’ 93.79% YoY growth outpacing the category blend and Vapor Pens expanding share from a small base to 6.01%, Persy’s positioning skews toward an access-led core in Capsules with opportunistic trial in inhalables, implying the next share gains will come from stabilizing Concentrates’ month-to-month swings while converting Vapor Pens’ momentum into a durable second pillar.
Competitive Landscape
Persy sits at #16 in ON Capsules in July 2026, up 4 ranks from #20 year over year, but flat versus April 2026 at #16; meanwhile, Glacial Gold advanced from #4 to #2 while growing sales 78.1% year over year, and Redecan slipped from #2 to #3 with a 34.7% sales decline, indicating Persy’s modest rank gain is happening amid rapid reshuffling where leaders are either accelerating or contracting more sharply—implying Persy’s trajectory suggests incremental share capture driven more by competitor volatility than by breakout momentum.
Notable Products
Glitterbomb Full Spectrum Live Rosin Disposable (0.5g) surged 315.97% month over month to rank 4, while Lot420 X Full Spectrum Cold Cured Live Rosin Batter (1g) fell 50.24% and sits effectively tied below rank 5, signaling a pivot from dabbable formats toward portable vapor pens. Strain Specific Full Spectrum Live Rosin Capsules 30-Pack (300mg) retained rank 1 despite a 3.96% decline, and Full Spectrum Cold Cured Live Rosin Batter (1g) slid 44.05% to rank 2, concentrating weakness in concentrates even as vapor pens rise. With two concentrates in the top five declining by over 44% and 50% alongside a 315.97% vapor pen spike, July 2026 points to a format shift favoring convenience over traditional rosin applications, implying Persy's near-term growth will skew toward inhalable and capsule-led portability rather than jarred concentrates.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
